Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician’s perspective
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Several studies have provided ample evidence of a clinically significant interobserver variation of the histological diagnosis of glioma. This interobserver variation has an effect on both the typing and grading of glial tumors. Since treatment decisions are based on histological diagnosis and grading, this affects patient care: erroneous classification and grading may result in both over- and undertreatment. In particular, the radiotherapy dosage and the use of chemotherapy are affected by tumor grade and lineage. It also affects the conduct and interpretation of clinical trials on glioma, in particular of studies into grade II and grade III gliomas. Although trials with central pathology review prior to inclusion will result in a more homogeneous patient population, the interpretation and external validity of such trials are still affected by this, and the question whether results of such trials can be generalized to patients diagnosed and treated elsewhere remains to be answered. Although molecular classification may help in typing and grading tumors, as of today this is still in its infancy and unlikely to completely replace histological classification. Routine pathology review in everyday clinical practice should be considered. More objective histological criteria for the grade and lineage of gliomas are urgently needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Histologic diagnosis and grading of gliomas have been limited by considerable intra- and interobserver variability (42).”
From Predicting cancer outcomes from histology and genomics using convolutional networks (2018) · cites this paper as [42]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, the grading criteria in the current classification schema for oligodendrogliomas continues to predominantly rely upon histopathologic examination; the differentiating criterion between grade 2 and grade 3 oligodendrogliomas are the presence of conspicuous microvascular proliferation and/or 6 mitoses per 10 high-power field [3,4,5,6,7,8,9,10,11].”
From BPC 157 Therapy of Myotendinous Junction Injury in Rats (2025) · cites this paper as [9]
Experimental — accuracy not yet measuredIn the citing paper
“Importantly, these data further facilitate consensus ratings on radiology images (e.g., MRI) of expert radiologists to alleviate inconsistencies that often arise due to subjective impressions and inter- and intra-observer variability [229].”
From AI in Medical Imaging Informatics: Current Challenges and Future Directions (2020) · cites this paper as [229]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,397
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
Rothwell, P. M. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17670-8 · Cited by 2,544 · cited 1×
“This issue is on the question of external validation or generalizability of the results of a trial, an often ignored element of clinical trials [26].”
BackgroundCairncross, J. G., Ueki, K., Zlatescu, M. C., Lisle, D. K., Finkelstein, D. M., Hammond, R. R., Silver, J. S., Stark, P. C., Macdonald, D. R., Ino, Y., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.19.1473 · Cited by 1,610
Feinstein, A. R., Sosin, D. M., & Wells, C. K. (1985) · New England Journal of Medicine · doi:10.1056/nejm198506203122504 · Cited by 1,544
An analysis of 8305 cases of carcinoid tumors
Modlin, I. M., & Sandor, A. (2000) · Cancer · doi:10.1002/(sici)1097-0142(19970215)79:4<813::aid-cncr19>3.0.co;2-2 · Cited by 1,200
Nutt, C. L., Mani, D. R., Betensky, R. A., Tamayo, P., Cairncross, J. G., Ladd, C., Pohl, U., Hartmann, C. J., McLaughlin, M. E., Batchelor, T. T., et al. (2003) · PubMed · Cited by 1,058
van den Bent, M., Afra, D., de Witte, O., Hassel, M. B., Schraub, S., Hoang-Xuan, K., Malmström, P.-O., Collette, L., Piérart, M., Mirimanoff, R., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67070-5 · Cited by 1,035
Wick, W., Hartmann, C., Engel, C., Stoffels, M., Felsberg, J., Stockhammer, F., Sabel, M. C., Koeppen, S., Ketter, R., Meyermann, R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.6497 · Cited by 809
Smith, J. S., Perry, A., Borell, T. J., Lee, H. K., O’Fallon, J., Hosek, S. M., Kimmel, D., Yates, A., Burger, P. C., Scheithauer, B. W., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.3.636 · Cited by 804
van den Bent, M. J., Carpentier, A. F., Brandes, A. A., Sanson, M., Taphoorn, M. J. B., Bernsen, H. J. J. A., Frenay, M., Tijssen, C. C., Grisold, W., Sipos, L., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.6078 · Cited by 748
Research works printed but not linked: 1
- Coons SW, Johnson PC, Scheithauer BW, Yates AJ, Pearl DK (1997) Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 79:1381–1391 · doi:10.1002/(sici)1097-0142(19970401)79:7<1381::aid-cncr16>3.0.co;2-w
Cited by
Items 101–200 of 640
Vision transformer-based weakly supervised histopathological image analysis of primary brain tumors
Li, Z., Cong, Y., Chen, X., Qi, J., Sun, J., Yan, T., Yang, H., Liu, J., Lu, E., Wang, L., et al. (2023) · iScience · doi:10.1016/j.isci.2022.105872 · Cited by 82
“Anaplastic Oligodendroglioma (AO) + (21) + (3) + (1)”
BackgroundInfluentialWood, M. D., Halfpenny, A. M., & Moore, S. R. (2019) · Diagnostic Pathology · doi:10.1186/s13000-019-0802-8 · Cited by 82
Diffusion tensor image features predict IDH genotype in newly diagnosed WHO grade II/III gliomas
Eichinger, P., Alberts, E., Delbridge, C., Trebeschi, S., Valentinitsch, A., Bette, S., Huber, T., Gempt, J., Meyer, B., Schlegel, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13679-4 · Cited by 75
Malzkorn, B., & Reifenberger, G. (2016) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000327 · Cited by 79
Spatial architecture of high-grade glioma reveals tumor heterogeneity within distinct domains
Moffet, J. J. D., Fatunla, E. O., Freytag, L., Kriel, J., Jones, J., Roberts-Thomson, S. J., Pavenko, A., Scoville, D., Zhang, L. N., Liang, Y., et al. (2023) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdad142 · Cited by 78
Gorlia, T., Delattre, J., Brandes, A. A., Kros, J. M., TAPHOORN, M. J. B., Kouwenhoven, M. C. M., Bernsen, H. J. J. A., Frénay, M., Tijssen, C. C., Lacombe, D. A., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.06.039 · Cited by 77
Survival and Prognostic Factors of Anaplastic Gliomas
Nuño, M., Birch, K. G., Mukherjee, D. R., Sarmiento, J. M., Black, K. L., & Patil, C. G. (2013) · Neurosurgery · doi:10.1227/01.neu.0000431477.02408.5e · Cited by 77
Grimm, S. A., & Chamberlain, M. C. (2016) · CNS Oncology · doi:10.2217/cns-2016-0002 · Cited by 77
Lee, M. K., Park, J. E., Jo, Y., Park, S. Y., Kim, S. J., & Kim, H. S. (2019) · European Radiology · doi:10.1007/s00330-019-06395-2 · Cited by 76
Jiang, S., Zanazzi, G. J., & Hassanpour, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-95948-x · Cited by 75
Ieva, A. D., Goed, S., Grabner, G., Grizzi, F., Sherif, C., Matula, C., Tschabitscher, M., & Trattnig, S. (2012) · Neuroradiology · doi:10.1007/s00234-012-1081-1 · Cited by 75
Cooper, L. A., Kong, J., Gutman, D. A., Dunn, W. D., Nalisnik, M., & Brat, D. J. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2014.153 · Cited by 61
SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II–III Diffuse Gliomas
Zhang, Y.-A., Zhou, Y., Luo, X., Song, K., Ma, X., Sathe, A. A., Girard, L., Xiao, G., & Gazdar, A. F. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.10.040 · Cited by 73
Pei, L., Jones, K. A., Shboul, Z. A., Chen, J. Y., & Iftekharuddin, K. M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.668694 · Cited by 73
Ryall, S. T., Tabori, U. Y., & Hawkins, C. E. (2017) · Brain Tumor Pathology · doi:10.1007/s10014-017-0282-z · Cited by 73
miRNA Multiplayers in glioma. From bench to bedside
Rolle, K. (2015) · Acta Biochimica Polonica · doi:10.18388/abp.2015_1072 · Cited by 72
Multiparametric MRI-based differentiation of WHO grade II/III glioma and WHO grade IV glioblastoma
Wiestler, B., Kluge, A., Lukas, M., Gempt, J., Ringel, F., Schlegel, J., Meyer, B., Zimmer, C., Förster, S., Pyka, T., et al. (2016) · Scientific Reports · doi:10.1038/srep35142 · Cited by 65
Jiang, H., Cui, Y., Wang, J., & Lin, S. (2016) · Oncotarget · doi:10.18632/oncotarget.13555 · Cited by 72
Wu, C., Jain, R., Radmanesh, A., Poisson, L., Guo, W., Zagzag, D., Snuderl, M., Placantonakis, D. G., Golfinos, J. G., & Chi, A. S. (2018) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5794 · Cited by 72
Ki-67/MIB-1 immunostaining in a cohort of human gliomas.
Skjulsvik, A. J., Mørk, J. N., Torp, M. O., & TORP, S. H. (2014) · Europe PMC (PubMed Central) · Cited by 69
Comelli, I., Lippi, G., Campana, V., Servadei, F., & Cervellin, G. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.06.12 · Cited by 69
Satomi, K., Ohno, M., Matsushita, Y., Takahashi, M., Miyakita, Y., Narita, Y., Ichimura, K., & Yoshida, A. (2020) · Modern Pathology · doi:10.1038/s41379-020-00701-w · Cited by 68
Liao, H., Xiong, T., Peng, J., Xu, L., Liao, M., Zhang, Z., Wu, Z., Yuan, K., & Zeng, Y. (2020) · Annals of Surgical Oncology · doi:10.1245/s10434-019-08190-1 · Cited by 65
Wesseling, P. (2012) · Springer eBooks · doi:10.1007/978-0-85729-458-6_1 · Cited by 64
DNA methylation profiling for molecular classification of adult diffuse lower-grade gliomas
Vega, S. F., Bontell, T. O., Corell, A., Smits, A., Jakola, A. S., & Carén, H. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01085-7 · Cited by 64
Kim, H., Yoon, H., Thakur, N., Hwang, G., Lee, E., Kim, C., & Chong, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-01905-z · Cited by 64
Molecular Markers in Low-Grade Glioma—Toward Tumor Reclassification
Olar, A., & Sulman, E. P. (2015) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2015.02.006 · Cited by 66
IDH1/2 mutation detection in gliomas
Arita, H., Narita, Y., Yoshida, A., Hashimoto, N., Yoshimine, T., & Ichimura, K. (2014) · Brain Tumor Pathology · doi:10.1007/s10014-014-0197-x · Cited by 63
Extracellular vesicles in glioblastoma: a challenge and an opportunity
Chandran, V. I., Gopala, S., Venkat, E. H., Kjølby, M., & Nejsum, P. L. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00600-2 · Cited by 62
Diagnostic Accuracy of Neuroimaging to Delineate Diffuse Gliomas within the Brain: A Meta-Analysis
Verburg, N., Hoefnagels, F. W. A., Barkhof, F., Boellaard, R., Goldman, S., Guo, J., Heimans, J. J., Hoekstra, O. S., Jain, R., Kinoshita, M., et al. (2017) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5368 · Cited by 61
Cancer Surgery 2.0: Guidance by Real-Time Molecular Technologies
Ogrinc, N., Saudemont, P., Takáts, Z., Salzet, M., & Fournier, I. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.04.001 · Cited by 61
[18F]-fluoro-l-thymidine PET and advanced MRI for preoperative grading of gliomas
Collet, S., Valable, S., Constans, J., Lechapt, E., Roussel, S., Delcroix, N., Abbas, A., Ibazizène, M., Bernaudin, M., Barré, L., et al. (2015) · NeuroImage Clinical · doi:10.1016/j.nicl.2015.05.012 · Cited by 61
Magnetic covalent organic framework nanospheres-based miRNA biosensor for sensitive glioma detection
Liang, D., Zhang, X., Wang, Y., Huo, T., Qian, M., Xie, Y., Li, W., Yu, Y., Shi, W., Liu, Q., et al. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.11.033 · Cited by 57
Mitotic Index Thresholds Do Not Predict Clinical Outcome for IDH-Mutant Astrocytoma
Yoda, R. A., Marxen, T., Longo, L., Ene, C. I., Wirsching, H., Keene, C. D., Holland, E. C., & Cimino, P. J. (2019) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlz082 · Cited by 57
Insights From Molecular Profiling of Adult Glioma
Diamandis, P., & Aldape, K. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.9516 · Cited by 56
Evolving Molecular Genetics of Glioblastoma
Li, Q.-J., Cai, J., & Liu, C.-Y. (2016) · Chinese Medical Journal · doi:10.4103/0366-6999.176065 · Cited by 56
Park, Y. W., Choi, Y. S., Ahn, S. S., Chang, J. H., Kim, S. H., & Lee, S. (2019) · Korean Journal of Radiology · doi:10.3348/kjr.2018.0814 · Cited by 55
Exploring Radiologic Criteria for Glioma Grade Classification on the BraTS Dataset
Dequidt, P., Bourdon, P., Tremblais, B., Guillevin, C., Gianelli, B., Boutet, C., Cottier, J., Vallée, J.-N., Fernández-Maloigne, C., & Guillevin, R. (2021) · IRBM · doi:10.1016/j.irbm.2021.04.003 · Cited by 54
MicroRNA as potential biomarkers in Glioblastoma
Areeb, Z., Stylli, S. S., Koldej, R. M., Ritchie, D. S., Siegal, T., Morokoff, A. P., Kaye, A. H., & Luwor, R. B. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1912-0 · Cited by 54
Price, M., Ryan, K. J., Shoaf, M. L., Neff, C., Iorgulescu, J. B., Landi, D. B., Cioffi, G., Waite, K. A., Kruchko, C., Barnholtz‐Sloan, J. S., et al. (2023) · Neuro-Oncology Practice · doi:10.1093/nop/npad061 · Cited by 53
Jiang, H., Ren, X., Cui, X., Wang, J., Jia, W., Zhou, Z., & Lin, S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not027 · Cited by 53
Chemotherapy for low-grade glioma: when, for whom, which regimen?
van den Bent, M. J. (2015) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000257 · Cited by 53
Combination genetic signature stratifies lower-grade gliomas better than histological grade
Chan, A. K., Yao, Y., Zhang, Z., Shi, Z., Chen, L., Chung, N. Y., Liu, J. S.-M., Li, K. K., Chan, D. T. M., Poon, W. S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4928 · Cited by 52
Rhun, E. L., Duhamel, M., Wisztorski, M., Gimeno, J., Zaïri, F., Escande, F., Reyns, N., Kobeissy, F. H., Maurage, C., Salzet, M., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2016.11.012 · Cited by 53
Preusser, M., Höftberger, R., Wöehrer, A., Gelpí, E., Kouwenhoven, M. C. M., Kros, J. M., Sanson, M., Idbaïh, A., Brandes, A. A., Heinzl, H., et al. (2012) · Histopathology · doi:10.1111/j.1365-2559.2011.04134.x · Cited by 51
The Effect of Molecular Diagnostics on the Treatment of Glioma
Bush, N. A. O., & Butowski, N. A. (2017) · Current Oncology Reports · doi:10.1007/s11912-017-0585-6 · Cited by 51
The Power of Human Cancer Genetics as Revealed by Low-Grade Gliomas
Jones, D., Bandopadhayay, P., & Jabado, N. (2019) · Annual Review of Genetics · doi:10.1146/annurev-genet-120417-031642 · Cited by 51
Magnetic Resonance Spectroscopy, Positron Emission Tomography and Radiogenomics—Relevance to Glioma
Chiang, G. C.-Y., Kovanlıkaya, İ., Choi, C., Ramakrishna, R. R., Magge, R., & Shungu, D. C. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00033 · Cited by 51
Grade II and III Oligodendroglioma and Astrocytoma
van den Bent, M. J., & Chang, S. M. (2018) · Neurologic Clinics · doi:10.1016/j.ncl.2018.04.005 · Cited by 51
Targeting Telomerase and ATRX/DAXX Inducing Tumor Senescence and Apoptosis in the Malignant Glioma
Fan, H., Chen, C., Chi, C.-S., Tsai, J., Chiang, K.-L., Chang, Y., Lin, S., & Harn, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010200 · Cited by 50
Galbraith, K., Vasudevaraja, V., Serrano, J., Shen, G., Tran, I., Abdallat, N., Wen, M., Patel, S. V., Movahed-Ezazi, M., Faustin, A., et al. (2023) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdad076 · Cited by 49
Duregon, E., Bertero, L., Pittaro, A., Soffietti, R., Rudà, R., Trevisan, M., Papotti, M. G., Ventura, L., Senetta, R., & Cassoni, P. (2016) · Oncotarget · doi:10.18632/oncotarget.8498 · Cited by 49
Towards machine learning-based quantitative hyperspectral image guidance for brain tumor resection
Black, D., Byrne, D., Walke, A., Liu, S., Ieva, A. D., Kaneko, S., Stummer, W., Salcudean, S. E., & Molina, E. S. (2024) · Communications Medicine · doi:10.1038/s43856-024-00562-3 · Cited by 48
Prognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma
Zhang, M., Wang, X., Chen, X., Guo, F., & Hong, J. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00441 · Cited by 48
Salvi, M., Molinari, F., Acharya, U. R., Molinaro, L., & Meiburger, K. M. (2021) · Computer Methods and Programs in Biomedicine Update · doi:10.1016/j.cmpbup.2021.100004 · Cited by 48
Overview of DNA methylation in adult diffuse gliomas
Aoki, K., & Natsume, A. (2019) · Brain Tumor Pathology · doi:10.1007/s10014-019-00339-w · Cited by 47
de Albuquerque, L. A. F., Almeida, J. P., Filho, L. D. M., Joaquim, A. F., & Duffau, H. (2020) · Neurosurgical Review · doi:10.1007/s10143-020-01362-8 · Cited by 47
Radiologists and Clinical Trials: Part 1 The Truth About Reader Disagreements
Schmid, A. M., Raunig, D. L., Miller, C. G., Walovitch, R. C., Ford, R. W., O’Connor, M., Brueggenwerth, G., Breuer, J., Kuney, L., & Ford, R. (2021) · Therapeutic Innovation & Regulatory Science · doi:10.1007/s43441-021-00316-6 · Cited by 47
Schepke, E., Löfgren, M., Pietsch, T., Bontell, T. O., Kling, T., Wenger, A., Vega, S. F., Danielsson, A., Dósa, S., Holm, S., et al. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12838 · Cited by 46
Sensitive and rapid detection ofTERTpromoter andIDHmutations in diffuse gliomas
Diplas, B. H., Liu, H., Yang, R. R., Hansen, L. J., Zachem, A. L., Zhao, F., Bigner, D. D., McLendon, R. E., Jiao, Y., He, Y., et al. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy167 · Cited by 46
Truong, A. H., Sharmanska, V., Limbӓck-Stanic, C., & Grech‐Sollars, M. (2020) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaa110 · Cited by 46
Latysheva, A., Emblem, K. E., Brandal, P., Vik-Mo, E. O., Pahnke, J., Røysland, K., Hald, J. K., & Server, A. (2019) · Neuroradiology · doi:10.1007/s00234-019-02173-5 · Cited by 45
Girardi, F., Rous, B., Stiller, C. A., Gatta, G., Fersht, N. L., Storm, H. H., Rodrigues, J. R., Herrmann, C., Marcos‐Gragera, R., Peris‐Bonet, R., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab067 · Cited by 45
Ieva, A. D., Bruner, E., Widhalm, G., Minchev, G., Tschabitscher, M., & Grizzi, F. (2012) · Scientific Reports · doi:10.1038/srep00429 · Cited by 43
Solheim, O. S., Tofte, K., Berger, C., & Torp, S. (2014) · Surgical Neurology International · doi:10.4103/2152-7806.146153 · Cited by 43
Schmid, D., Warnken, U. H., Latzer, P., Hoffmann, D. C., Roth, J., Kutschmann, S., Jaschonek, H., Rübmann, P., Foltyn‐Dumitru, M., Vollmuth, P., et al. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15350 · Cited by 43
Balañá, C., Castañer, S., Carrato, C., Morán, T., Lopez‐Paradís, A., Doménech, M., Hernández, A., & Puig, J. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.865171 · Cited by 43
van Kempen, E. J., Post, M., Mannil, M., Küsters, B., ter Laan, M., Meijer, F. J. A., & Henssen, D. J. H. A. (2021) · Cancers · doi:10.3390/cancers13112606 · Cited by 42
Shim, W. S., Yim, K., Kim, T. J., Sung, Y. E., Lee, G., Hong, J. H., Chun, S. H., Kim, S., An, H. J., Na, S. J., et al. (2021) · Cancers · doi:10.3390/cancers13133308 · Cited by 42
Artificial Intelligence–Assisted Classification of Gliomas Using Whole Slide Images
Jose, L., Liu, S., Russo, C., Cong, C., Song, Y., Rodriguez, M. L., & Ieva, A. D. (2022) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2021-0518-oa · Cited by 42
Ostrom, Q. T., Kinnersley, B., Armstrong, G., Rice, T., Chen, Y., Wiencke, J. K., Mccoy, L. S., Hansen, H. M., Amos, C. I., Bernstein, J. L., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31759 · Cited by 42
Castet, F., Alanya, E., Vidal, N., Izquierdo, C., Mesía, C., Ducray, F., Gil‐Gil, M., & Bruna, J. (2019) · Journal of Neuro-Oncology · doi:10.1007/s11060-019-03183-2 · Cited by 41
Schiff, D. (2015) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000464174.88687.79 · Cited by 41
Price, M., Ballard, C. A. P., Benedetti, J. R., Kruchko, C., Barnholtz‐Sloan, J. S., & Ostrom, Q. T. (2025) · Neuro-Oncology · doi:10.1093/neuonc/noaf168 · Cited by 40
Studying a Complex Tumor: Potential and Pitfalls
Zheng, S., Chheda, M. G., & Verhaak, R. G. W. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e3182431c57 · Cited by 41
Incorporating Advances in Molecular Pathology Into Brain Tumor Diagnostics
Vega, J. E. V., & Brat, D. J. (2018) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000186 · Cited by 40
Involvement of Thyroid Hormones in Brain Development and Cancer
Schiera, G., Liegro, C. M. D., & Liegro, I. D. (2021) · Cancers · doi:10.3390/cancers13112693 · Cited by 41
IDHMutations: Genotype-Phenotype Correlation and Prognostic Impact
Wang, X.-W., Ciccarino, P., Rossetto, M., Boisselier, B., Marie, Y., Desestret, V., Gleize, V., Mokhtari, K., Sanson, M., & Labussière, M. (2014) · BioMed Research International · doi:10.1155/2014/540236 · Cited by 40
A new NFIA:RAF1 fusion activating the MAPK pathway in pilocytic astrocytoma
Yde, C. W., Sehested, A. M., Mateu‐Regué, À., Østrup, O., Scheie, D., Nysom, K., Nielsen, F. C., & Rossing, M. (2016) · Cancer Genetics · doi:10.1016/j.cancergen.2016.09.002 · Cited by 40
de Mendonça, M. L., Coletti, R., Gonçalves, C. S., Martins, E. P., Costa, B. M., Vinga, S., & Lopes, M. B. (2025) · Scientific Data · doi:10.1038/s41597-025-05117-2 · Cited by 40
Histo-genomics: digital pathology at the forefront of precision medicine
Barsoum, I. B., Tawedrous, E., Faragalla, H., & Yousef, G. M. (2018) · Diagnosis · doi:10.1515/dx-2018-0064 · Cited by 40
Prognostic significance of MEOX2 in gliomas
Tachon, G., Masliantsev, K., Rivet, P., Petropoulos, C., Godet, J., Milin, S., Wager, M., Guichet, P., & Karayan, L. (2019) · Modern Pathology · doi:10.1038/s41379-018-0192-6 · Cited by 39
Ostrom, Q. T., Gittleman, H. R., Kruchko, C., Louis, D. N., Brat, D. J., Gilbert, M. R., Petkov, V. I., & Barnholtz‐Sloan, J. S. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2217-7 · Cited by 39
Saini, J. S., Gupta, P. K., Sahoo, P., Singh, A., Patir, R., Ahlawat, S., Beniwal, M., Thennarasu, K., Santosh, V., & Gupta, R. K. (2017) · Neuroradiology · doi:10.1007/s00234-017-1942-8 · Cited by 38
Du, N., Zhou, X., Mao, R., Shu, W., Li, X., Yao, Y., Xu, X., Shen, Y., Lin, G., Fang, X., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.873839 · Cited by 38
Gladitz, J., Klink, B., & Seifert, M. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0544-y · Cited by 37
WHO grade has no prognostic value in the pediatric high-grade glioma included in the HERBY trial
Varlet, P., Teuff, G. L., Deley, M. L., Giangaspero, F., Haberler, C., Jacques, T. S., Figarella‐Branger, D., Pietsch, T., Andreiuolo, F. D. M., Deroulers, C., et al. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz142 · Cited by 37
Schiff, D. (2017) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000537 · Cited by 37
Molecular genetics of adult grade II gliomas: towards a comprehensive tumor classification system
Figarella‐Branger, D., Bouvier, C., de Paula, A. M., Mokhtari, K., Colin, C., Loundou, A., Chinot, O. L., & Métellus, P. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-0953-x · Cited by 37
‘Low grade glioma’: an update for radiologists
Larsen, J., Wharton, S. B., McKevitt, F. M., Romanowski, C. A. J., Bridgewater, C. H., Zaki, H., & Hoggard, N. (2017) · British Journal of Radiology · doi:10.1259/bjr.20160600 · Cited by 38
Central Pathology Review for Phase III Clinical Trials: The Enabling Effect of Virtual Microscopy
Mróz, P., Parwani, A. V., & Kulesza, P. (2013) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2012-0093-ra · Cited by 37
Ni, J., Zhang, H., Yang, Q., Fan, X., Xu, J., Sun, J., Zhang, J., Hu, Y., Xiao, Z., Zhao, Y., et al. (2024) · Academic Radiology · doi:10.1016/j.acra.2024.02.009 · Cited by 36
Wang, Z., Mo, Y., Tan, Y., Wen, Z., Dai, Z., Zhang, H., Zhang, X., Feng, S., Liang, X., Song, T., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.756606 · Cited by 36
Low-grade and anaplastic oligodendroglioma
van den Bent, M. J., Bromberg, J. E. C., & Buckner, J. C. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802997-8.00022-0 · Cited by 36
Multiple Molecular Data Sets and the Classification of Adult Diffuse Gliomas
Ellison, D. W. (2015) · New England Journal of Medicine · doi:10.1056/nejme1506813 · Cited by 36
Molecular profiling of gliomas: potential therapeutic implications
Alentorn, A., Durán-Peña, A., Pingle, S. C., Piccioni, D. E., Idbaïh, A., & Kesari, S. (2015) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2015.1062368 · Cited by 35
Single-session Gamma Knife radiosurgery for optic pathway/hypothalamic gliomas
El-Shehaby, A. M. N., Reda, W. A. H., Abdelkarim, K., Eldin, R. M. E., & Nabeel, A. M. (2016) · Journal of neurosurgery · doi:10.3171/2016.8.gks161432 · Cited by 35
Identification of the Prognostic Signatures of Glioma With Different PTEN Status
Zhang, P., Meng, X., Liu, L., Li, S., Li, Y., Ali, S., Li, S., Xiong, J., Liu, X., Li, S., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.633357 · Cited by 35
Melatonergic system‐based two‐gene index is prognostic in human gliomas
Kinker, G. S., Oba‐Shinjo, S. M., Carvalho‐Sousa, C. E., Muxel, S. M., Marie, S. K. N., Markus, R. P., & Fernandes, P. A. C. M. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12293 · Cited by 35
Gamma Knife radiosurgery for low-grade tectal gliomas
El-Shehaby, A. M. N., Reda, W. A. H., Abdelkarim, K., Eldin, R. M. E., & Esene, I. N. (2014) · Acta Neurochirurgica · doi:10.1007/s00701-014-2299-y · Cited by 35
Metadata
- Authors
- van den Bent, M. J.
- Venue
- Acta Neuropathologica
- Published
- 2010-07-20
- Volume
- 120
- Issue
- 3
- Pages
- 297-304
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC2910894
- OpenAlex
- W2112567075
- Cited by
- 577
- References
- 35
- Citations by year
- 2026: 19 · 2025: 36 · 2024: 70 · 2023: 43 · 2022: 43 · 2021: 47 · 2020: 48 · 2019: 52 · 2018: 33 · 2017: 46 · 2016: 44 · 2015: 33 · 2014: 16 · 2013: 16 · 2012: 20
- FWCI
- 6.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Acta Neuropathologica (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Reliability and Agreement in Measurement
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
- Keywords
- glioma, interobserver variability, histopathological diagnosis, tumor grading, tumor classification, central pathology review, clinical trial interpretation, generalizability, molecular classification, chemotherapy
- MeSH terms
- Brain Neoplasms, Clinical Trials as Topic, Glioma, Humans, Observer Variation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.